Desk› Healthcare› Rubicon Research Ltd
Rubicon Research Ltd
Filing rhythm · 60 trading days
24 filings · 5 material · busiest 2026-08-14
What it files
Filings
24 in the window
-
19 August 2026
Concall TranscriptEarnings Call Transcript
Trascript of Earnings Call Q1 FY 2026-27
Company Update / Earnings Call Transcript View filing →
-
14 August 2026
Board OutcomeBoard Meeting Outcome for Unaudited Financials Results For Quarter Ended June 30, 2026
Unaudited Financials Results for Quarter ended June 30, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
14 August 2026
Investor PresentationInvestor Presentation
Investor Presentation
Company Update / Investor Presentation View filing →
-
14 August 2026
Change in ManagementChange in Management
Disclosure under Regulation 30 (SEBI LODR) Outcome of Board Meeting
Company Update / Change in Management View filing →
-
14 August 2026
Monitoring AgencyMonitoring Agency Report
Monitoring Agency Report for the Quarter ended June 30, 2026.
Company Update / Monitoring Agency Report View filing →
-
14 August 2026
GeneralAudio Recording Of Earnings Conference Call For The Quarter Ended 30Th June, 2026.
Audio Recording of earnings conference call for the quarter ended 30th June, 2026
Company Update / General View filing →
-
13 August 2026
Annual ReportReg. 34 (1) Annual Report.
Corrigendum to the Integrated Annual Report for the financial year 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
11 August 2026
Annual ReportReg. 34 (1) Annual Report.
Notice of 27th Annual General Meeting along with the Intergrated Annual report for FY 2025-26.
Others / Reg. 34 (1) Annual Report View filing →
-
7 August 2026
Board MeetingBoard Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026
Rubicon Research Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve The Un-Audited Standalone ....
Board Meeting / Board Meeting View filing →
-
7 August 2026
-
4 August 2026
Newspaper PublicationNewspaper Publication
Newspaper Advertisment titled Notice of the 27th Annual General Meeting and voting Information
Company Update / Newspaper Publication View filing →
-
3 August 2026
AGM / EGMNotice Of 27Th Annual General Meeting Along With Integrated Annual Report Of The Company For The Financial Year 2025-26 And Letter For Weblink To Access Notice And The Integrated Annual Report
Notice of 27th Annual General Meeting along with Integrated Annual Report of the Company for the financial year 2025-26 and Letter for weblink to access Notice and the Integrated Annual Report
AGM/EGM / AGM View filing →
-
3 August 2026
BRSRBusiness Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainabilty Report for the Financial Year 2025-26
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
30 July 2026
GeneralNewspaper Advertisement Titled 'Information Regarding 27Th Annual General Meeting To Be Held Through Video Conferencing/ Other Audio-Visual Means, Final Dividend And Record Date Information
Newspaper ADvertisement titled "Information Regarding 27th Annual General Meeting to be held through Video Conferencing/Other Audio-Visual Means, Final Dividend and Record Date Intimation
Company Update / General View filing →
-
29 July 2026
GeneralCommunication On Tax Deduction At Source On Dividend
Communication on tax deduction at source on Dividend
Company Update / General View filing →
-
22 July 2026
Press ReleasePress Release / Media Release
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015 ('SEBI Listing Regulations') - Acquisition of a Manufacturing Facility in USA.
Company Update / Press Release / Media Release View filing →
-
22 July 2026
GeneralFiling Of Scheme Of Merger Of Kia Health Tech Private Limited (Wholly Owned Subsidiary) With Rubicon Research Limited - For Disclosure Purposes Only, In Terms Of The Exemption Under Paragraph 4 Of SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 Dated June 20, 2023
Filing of Scheme of Merger of KIA Health Tech Private Limited (WOS) with Rubicon Research Limited - for disclosure purposes only, in terms of the Exemption under Para 4 of SEBI Master Circular ....
Company Update / General View filing →
-
22 July 2026
GeneralFiling Of Scheme Of Merger Of Kia Health Tech Private Limited (Wholly Owned Subsidiary) With Rubicon Research Limited - For Disclosure Purposes Only, In Terms Of The Exemption Under Paragraph 4 Of SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 Dated June 20, 2023
Filing of Scheme of Merger of KIA Health Tech Pvt Ltd (WOS) with Rubicon Research Limited - for Disclosure Purposes Only, in terms of the Exemption under Para 4 of SEBI Master circular ....
Company Update / General View filing →
-
20 July 2026
ESOP AllotmentAllotment of ESOP / ESPS
Allotment of ESOP
Company Update / Allotment of ESOP / ESPS View filing →
-
20 July 2026
GeneralOutcome Of Board Meeting
1. Date of 27th AGM and Record date for payment of final dividend for FY 2025-26. 2. Update on merger of KIA Health Tech Private Limited, WOS with Rubicon Research Ltd.
Company Update / General View filing →
-
20 July 2026
Record DateRecord Date For Payment Of Final Dividend - Friday, August 7, 2026
Date of 27th AGM and Record date for payment of final dividend.
Corp. Action / Record Date View filing →
-
9 July 2026
Compliance CertificateCertificate Under Regulation 74(5) Of SEBI (Depositories And Participants) Regulations, 2018 For The Quarter Ended June 30, 2026.
Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended June 30, 2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
3 July 2026
GeneralDisclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - US FDA Inspection Of The Company'S Manufacturing Facility In Pithampur, Madhya Pradesh
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - US FDA inspection of Company's manufacturing facility in Pithampur, Madhya Pradesh.
Company Update / General View filing →
-
29 June 2026
Trading WindowClosure of Trading Window
Intimation of Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →